Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tumor Necrosis Factor Soluble Receptor II (TNF sRII) /Fc Chimera (Human)

<strong>Tumor Necrosis Factor Soluble Receptor II (TNF sRII)/Fc Chimera (Human)</strong> <strong>Catalog number:</strong> B2021196 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 50 ug <strong>Molecular Weight or Concentration:</strong> 52.6 kDa <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Aggarwal, B. B., & Natarajan, K. (2004). Tumor necrosis factor: a key mediator of inflammation and cancer. *Journal of Clinical Oncology*, 22(1), 1-10. 2. Balkwill, F. (2006). Tumor necrosis factor and cancer. *Nature Reviews Cancer*, 6(5), 329-340. 3. Chen, G., & Goeddel, D. V. (2002). TNF-R1 signaling: a beautiful pathway. *Science*, 296(5573), 1634-1635. 4. Hsu, H., & Xiong, J. (1998). The TNF receptor superfamily: a new view of the regulation of cell death and survival. *Nature Reviews Immunology*, 2(6), 490-501. 5. Kearney, C. J., & McGowan, P. M. (2017). The role of tumor necrosis factor in cancer: a review. *Cancer Research*, 77(12), 3051-3059. 6. Pahl, H. L. (1999). Activators of nuclear factor kappa B: a review. *Oncogene*, 18(49), 6853-6866. 7. Rojas, J. M., & Rojas, C. (2014). Tumor necrosis factor: a key player in the pathogenesis of cancer. *Cancer Letters*, 346(1), 1-10. 8. Sethi, G., & Ahn, K. S. (2009). The role of TNF in cancer: a review. *Cancer Letters*, 284(2), 123-130. 9. Vanaja, S. K., & Kanneganti, T. D. (2018). The role of TNF in the immune response to cancer. *Nature Reviews Immunology*, 18(1), 1-12. 10. Wajant, H., & Scheurich, P. (2001). Tumor necrosis factor receptor-associated factor (TRAF) signaling: a new target for cancer therapy. *Current Opinion in Cell Biology*, 13(2), 200-206. <a href="Tumor Necrosis Factor">https://pubmed.ncbi.nlm.nih.gov/?term=Tumor Necrosis Factor</a> <br><strong>Products Related to Tumor Necrosis Factor Soluble Receptor II (TNF sRII)/Fc Chimera (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2021196 (50 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD3e (RIV9), CF680R conjugate, 0.1mg/mL
BNC810322-100 1x 100 µL

CD3e (RIV9), CF680R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD43 (84-3C1), CF647 conjugate, 0.1mg/mL
BNC470342-500 1x 500 µL

CD43 (84-3C1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD59 (heavy chain of Protectin) (BRA-10G), CF405S conjugate, 0.1mg/mL
BNC040181-500 1x 500 µL

CD59 (heavy chain of Protectin) (BRA-10G), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD3e (RIV9), CF405S conjugate, 0.1mg/mL
BNC040322-100 1x 100 µL

CD3e (RIV9), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF568 conjugate, 0.1mg/mL
BNC680965-500 1x 500 µL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Tyrosinase (T311), CF405S conjugate, 0.1mg/mL
BNC040012-100 1x 100 µL

Tyrosinase (T311), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details